WEST JEFFERSON, North Carolina, July 3 /PRNewswire/ --

- Company Offers Clubs, Pubs, Casinos, and Business People Nicotine Fix 
Without The Smoke

Next Safety, Inc.'s pulmonary drug delivery device delivers nicotine more
effectively than a cigarette, without the smoke. This device has enormous
potential in the United Kingdom, where no-smoking bans have recently gone
into effect. The Health Bill, which was approved to take effect summer 2007,
bans cigarettes and tobacco use inside public pubs, as well as private member
establishments. The pulmonary drug delivery device is an extremely useful
tool in keeping smoking patrons and workers happy in everyday settings.
Persons using the hand held device still get the nicotine "hit" that they
crave, but won't be breaking any new "no-smoking" laws. The company looks
forward to working with the National Health Service organisations to support
their important leadership in removing the carcinogens from public spaces.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070615/CLF038LOGO )

"Next Safety, Inc. offers a safe, cost effective alternative to smoking
that we believe will save millions of lives," said C. Eric Hunter, CEO and
founder of Next Safety, Inc. "Next Safety's position is that cigarette
smoking is harmful. We are certain that this realistic approach will be far
more effective and much safer than smoking a cigarette. It will allow public
and private establishments to operate without losing the revenue of a smoking
public."

Roughly the size of a pack of cigarettes, the device will be used in much
the same way as current inhalers. The nicotine is supplied by replaceable
cartridges; the cartridges are monitored by electronically stored information
to ensure safe dosing. Battery powered circuitry monitors the system to
create and deliver an aerosol to the lungs at the optimal point during
inhalation. The aerosol is delivered through a mouthpiece connected to the
system by a flexible hose.

Initially, the unit will be provided to unregulated global markets with
availability in other areas following regulatory compliance. Next Safety,
Inc. anticipates production volumes will reach more than one million units
monthly in the first quarter of 2008. Primary manufacturing capacity will be
provided through contract-manufacturing firms and a significant expansion of
Next Safety's West Jefferson, North Carolina, USA facility.

In addition to nicotine, Next Safety will soon launch drug delivery tests
utilizing its pulmonary drug delivery method and devices that will include
antibiotics (tobramycin), anti-emetics (promethazine), bronchodilators
(albuterol), and narcotics (morphine).

About Next Safety, Inc.

Next Safety is located in North Carolina, an area already known for
leadership in technology and medicine. The company has leveraged this
expertise to develop the worlds most advanced respirator technology and to
advance the field of pulmonary medicine. Next Safety's bPure8000(TM) line of
respirators provide higher protection against airborne viruses and fine
particulate air pollution than any other respirator available globally. Next
Safety now brings the same innovative approach to the science of pulmonary
drug delivery and nicotine replacement.

For more information about Next Safety, Inc. visit www.NextSafety.com

Web site: http://www.nextsafety.com